Rethinking European Expansion: What Life Science Leaders Can Learn from Latvia Verified listing

For years, global life science companies have focused on a familiar set of European markets for expansion. That conversation is changing as Latvia gains attention for its EU access, skilled workforce and growing biomedicine ecosystem. This webinar will explore why Latvia is emerging as a life science investment destination and what organizations should know when evaluating it for European expansion.

Tucked at the crossroads of Northern and Eastern Europe, Latvia offers a combination of agility, access and ambition that can be harder to find in larger, more established markets. It sits within the EU, with regulatory alignment, a highly educated multilingual workforce and a competitive business environment. And yet it remains, for many decision-makers, an undiscovered opportunity.

Latvia’s biomedicine sector has grown significantly over the past several years, not just in size, but in depth and sophistication. World-class research institutions, a strong university pipeline, dedicated Special Economic Zones, and a national innovation platform built to translate science into commercial solutions are all part of an ecosystem that is maturing quickly. Global companies across pharmaceuticals, diagnostics, genomics, digital health, and shared services have already made Latvia their European base and continue to grow there.

In this webinar, the LIAA Investment Attraction team will share what that journey looks like from the inside: what draws international companies to Latvia, what they find when they arrive and how LIAA supports them at every stage, from the first conversation through site selection, regulatory navigation, talent access and long-term growth.

Attendees will gain a practical view of Latvia’s life science investment landscape, including its biomedicine ecosystem, operating environment, talent base, incentive structures and role as a potential European location for R&D, manufacturing, clinical operations or shared services.

Register for this webinar to learn why Latvia is emerging as a life science investment destination for European expansion.